NDC 59572-402

Revlimid

Lenalidomide

Revlimid is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Celgene Corporation. The primary component is Lenalidomide.

Product ID59572-402_1f462eb0-4995-4b06-93ce-27e3fcbe32d5
NDC59572-402
Product TypeHuman Prescription Drug
Proprietary NameRevlimid
Generic NameLenalidomide
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2012-04-16
Marketing CategoryNDA / NDA
Application NumberNDA021880
Labeler NameCelgene Corporation
Substance NameLENALIDOMIDE
Active Ingredient Strength3 mg/1
Pharm ClassesThalidomide Analog [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 59572-402-00

100 CAPSULE in 1 BOTTLE (59572-402-00)
Marketing Start Date2012-05-09
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 59572-402-28 [59572040228]

Revlimid CAPSULE
Marketing CategoryNDA
Application NumberNDA021880
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2012-05-09

NDC 59572-402-00 [59572040200]

Revlimid CAPSULE
Marketing CategoryNDA
Application NumberNDA021880
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2012-05-09

Drug Details

Active Ingredients

IngredientStrength
LENALIDOMIDE2.5 mg/1

OpenFDA Data

SPL SET ID:5fa97bf5-28a2-48f1-8955-f56012d296be
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 643712
  • 643714
  • 1429367
  • 643720
  • 643722
  • 1242231
  • 1242233
  • 1428947
  • 602910
  • 616114
  • 602912
  • 616116
  • Pharmacological Class

    • Thalidomide Analog [EPC]

    NDC Crossover Matching brand name "Revlimid" or generic name "Lenalidomide"

    NDCBrand NameGeneric Name
    59572-402RevlimidLenalidomide
    59572-405RevlimidLenalidomide
    59572-410RevlimidRevlimid
    59572-425RevlimidRevlimid
    59572-415RevlimidRevlimid
    59572-420RevlimidRevlimid
    0378-1936LenalidomideLenalidomide
    0378-1937LenalidomideLenalidomide
    0378-1940LenalidomideLenalidomide
    0378-1941LenalidomideLenalidomide
    0480-1242LenalidomideLenalidomide
    0480-1243LenalidomideLenalidomide
    0480-1244LenalidomideLenalidomide
    0480-1246LenalidomideLenalidomide
    43598-511LenalidomideLenalidomide
    43598-512LenalidomideLenalidomide
    43598-513LenalidomideLenalidomide
    43598-514LenalidomideLenalidomide
    43598-515LenalidomideLenalidomide
    43598-516LenalidomideLenalidomide
    47781-484LENALIDOMIDELenalidomide
    47781-485LENALIDOMIDELenalidomide
    47781-486LENALIDOMIDELenalidomide
    47781-488LENALIDOMIDELenalidomide

    Trademark Results [Revlimid]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    REVLIMID
    REVLIMID
    78795942 3255216 Live/Registered
    Celgene Corporation
    2006-01-20
    REVLIMID
    REVLIMID
    78290583 3074309 Live/Registered
    Celgene Corporation
    2003-08-21
    REVLIMID
    REVLIMID
    78188450 2925808 Live/Registered
    Celgene Corporation
    2002-11-25
    REVLIMID
    REVLIMID
    76631301 3169244 Live/Registered
    Celgene Corporation
    2005-02-14

    © 2022 FDA.report
    This site is not affiliated with or endorsed by the FDA.